CAS: 55750-48-6; Methyl 2,5-Dioxo-2,5-Dihydro-1H-Pyrrole-1-Carboxylate

该化合物是多用途化学中间体,广泛用于有机合成和聚合物化学,其主要优点包括作为Diels-Alder反应的死神的高反应性反应能力及其参与Michael添加剂的能力,使其对构建复杂的分子框架具有价值.甲氧碳基集团提高了有机溶剂的溶解性,为处理和反应条件提供了便利.该化合物在改变生物分子和合成功能聚合物方面特别有用,因为其阳性团结使得它能够有选择地与硫醇集团融合.其环境条件稳定,并且定义明确的再活动特征使它成为研究和工业应用的可靠选择.

结构式图片

相似化合物

55750-49-7 1442447-48-4 930-88-1

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号541-59-3 马来酰亚胺 | CAS号79-22-1 氯甲酸甲酯 | CAS号2126-93-4 (3S,8S,9S,10R,1... | CAS号141-78-6 乙酸乙酯 | CAS号4856-87-5 1,6-二(马来酰亚胺基)己烷 | CAS号5132-30-9 1,2-双(马来酰亚胺)乙烷 | CAS号27574-80-7 1,1'-(十二烷-1,12-... | CAS号28537-73-7 1,8-双(马来酰亚胺顺丁烯二... | CAS号28537-70-4 1,4-双(马来酰亚胺基)丁烷 | CAS号541-59-3 马来酰亚胺 | CAS号134272-63-2 N-B°C-2-氨乙基马来酰亚胺 | CAS号34321-81-8 Mal-PEG2-alcohol | CAS号34321-80-7 n-(3-hydroxypro... | CAS号157503-18-9 1-(6-羟基己基)-1H-吡...

合成工艺路线路线简述

    马来酰亚胺,氯甲酸甲酯 反应 1.0H,反应生成 N-甲氧基羰基顺丁烯二酰亚胺
    参考文献:在定制控制释放的碳酸盐/氨基甲酸酯键与还原键敏感的二硫键连接基团之间寻求平衡:原位共价结合白蛋白的吉西他滨前药可促进生物利用度和肿瘤蓄积.
    标题:在定制控制释放的碳酸盐/氨基甲酸酯键与还原键敏感的二硫键连接基团之间寻求平衡:原位共价结合白蛋白的吉西他滨前药可促进生物利用度和肿瘤蓄积.
    摘要:为了解决快速酶灭活,不良肿瘤靶向以及吉西他滨(gem)应用中获得的耐药性的挑战,我们报道了两组由马来酰亚胺官能化的gem前药与血液循环白蛋白的cys-34共价共价结合,然后产生静脉给药后在大分子前药中的作用.通过链接键的不同组合(相对稳定和不稳定(分别为氨基甲酸酯和碳酸酯)以及带有或不带有二硫键的连接子)可以实现量身定制的精确控制释放.有趣的是,我们发现二硫键带来的总体优缺点随着连接键的稳定性而变化.最后,带有碳酸酯键的基团,尤其是带有缺乏二硫键的连接基的基团,体内抗肿瘤功效.
    DOI:10.1021/acs.Jmedchem.8B00293

    海关参考信息

    专利信息


    专利号:US-11945838-B2
    优先权日:2018-12-20
    标 题:Method for synthesis of protein amphiphiles
    发明人:BRITTO Sandanaraj Selvaraj; REDDY Mullapudi Mohan
    权利人:INDIAN INSTITUTE OF SCIENCE EDUCATION AND RES
    摘要:The present invention discloses a novel cost effective method for synthesis of protein/peptide amphiphiles irrespective of functional and structural classification of proteins useful in designing a vaccine candidate from antigenic protein. The protein modification of the present invention is universal and hence any protein/peptide can be converted into amphiphilic proteins/peptides.

    专利号:US-6262251-B1
    优先权日:1995-10-19
    标题 :Method for solution phase synthesis of oligonucleotides
    发明人:PIEKEN WOLFGANG; MCGEE DANNY; SETTLE ALECIA; ZHAI YANSHENG; HUANG JIANPING
    权利人:PROLIGO LLC
    摘要:This invention discloses an improved method for the sequential solution phase synthesis of oligonucleotides. The method lends itself to automation and is ideally suited for large scale manufacture of oligonucleotides with high efficiency.

    专利号:US-2025250302-A1
    优先权日:2024-02-05
    标题:Synthesis of self-assembling artificial proteins utilizing a host-guest system and uses thereof
    发明人:SANDANARAJ BRITTO S; KHYADE ASHWINI RAJENDRA; HATI KSHITISH CHANDRA
    权利人:INDIAN INSTITUTE OF SCIENCE EDUCATION AND RES PUNE IISER PUNE
    摘要:The invention relates to an efficient method for synthesizing self-assembling artificial proteins (SAPs) utilizing a catalytic host-guest system. The process involves encapsulating hydrophobic probes with cyclodextrin, performing site-specific protein bioconjugation, and employing a second catalysis cycle for enhanced labeling. SAPs produced through this method are versatile and find applications in therapeutic delivery and diagnostics. The process is simplified, scalable, cost-effective, and environmentally sustainable, addressing the challenges of traditional SAP synthesis. By offering improved yield, functionality, and structural integrity, this invention advances the potential of SAPs in medical and industrial fields.

    专利号:US-11359004-B2
    优先权日:2012-04-03
    标 题:Succinimide-activated nitroxyl compounds and methods for the use thereof for nitroxylation of proteins
    发明人:VANDEGRIFF KIM D; MALAVALLI ASHOK; MKRTCHYAN GNEL
    权利人:SCHINDLER WILLIAM
    摘要:The present invention relates to succinimide-activated nitroxyl compounds and methods for the synthesis of such compounds. The present invention also relates to the use of succinimide-activated nitroxyl compounds to prepare nitroxylated proteins, for example nitroxylated heme proteins (e.g., nitroxylated hemoglobin and nitroxylated myoglobin). The nitroxylated proteins are optionally also conjugated to a polyalkylene oxide (PAO), for example to a polyethylene glycol (PEG). Polynitroxylated heme proteins are useful as oxygen therapeutic agents (OTAs). The invention further relates to pharmaceutical compositions of the nitroxylated proteins and methods for the use of nitroxylated proteins in the treatment of various conditions.

    专利号:US-5262524-A
    优先权日:1990-03-09
    标题 :Method for the synthesis of trifunctional maleimide-antibody complex
    发明人:ANDERSON LESLIE D; AHLEM CLARENCE N; HUANG ANN E
    权利人:HYBRITECH INC
    摘要:The present invention is directed to a method for extending the length of one of the three linker arms of the compound of Formula I in the production of novel trifunctional antibody-like compounds. Formula I is defined as follows: wherein X is wherein k=1 or 0; wherein Z is wherein s=1 or 0; wherein n=1 or 0; wherein q=1 or 0; wherein Y is wherein Y' is wherein p or m may be the same or different and are integers ranging from 0 to 20 with the provisos that when n=0, the sum of m and p is an integer ranging from 1 to 20, whereas when n=1, p and m are each an integer that is at least 1 and the sum of p and m is an integer ranging from 2 to 20; wherein R1 is straight or branched chain lower alkyl having from 1 to 6 carbon atoms or lower alkoxy having from 1-6 carbon atoms; and wherein R2 is hydrogen, phenyl, -COOH, or straight or branched chain lower alkyl having from 1-6 carbon atoms, with the proviso that the lower alkyl moiety may be mono substituted by -NH2, -OH, or -COOH. The compound of the present invention is useful as a trivalent coupling agent for linking Fab'-like fragments to form both bifunctional and trifunctional antibody-like compounds.

    专利号:US-2020199175-A1
    优先权日:2018-12-20
    标题 :Method for synthesis of protein amphiphiles
    北京上草生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.china-api.cn
    企业联系电话:010-51288246👤
    📞北京上草生物科技有限公司 ⚠️参考联系方式
    联系人:杨先生
    电话:010-51288246

    传真:010-56495849
    邮箱:300abc@sina.com
    通信地址: 北京市通州区金桥科技产业基地景盛南四街17号联东U谷58号楼
    邮编: 101102
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:北京市通州区金桥科技产业基地景盛南四街17号联东U谷58号楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Susanne Kirchhof, Et Al. Diels-Alder Hydrogels With Enhanced Stability: First Step Toward Controlled Release Of Bevacizumab. Eur J Pharm Biopharm. 2015 Oct:96:217-25.

    合成参考文献


    参考文献:10.1016/s0968-0896(02)00339-5
    摘要:Wang LX, Ni J, Singh S. Carbohydrate-centered maleimide cluster as a new type of templates for multivalent peptide assembling. synthesis of multivalent HIV-1 gp41 peptides. Bioorg Med Chem. 2003 Jan 02;11(1):159–66. doi: 10.1016/s0968-0896(02)00339-5.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知